Wow, antiviral pill taken within 3d of symptoms COVID: 89% reduction in hospitalization or death
Another @pfizer home run!
Protease inhibitor originally developed for SARS-Cov1 in 2003 and now repurposed!
https://t.co/hD6d2DbOBk
Yet another brilliant, makes-you-stop-and-think-about-it article about #marketing by @markwschaefer...
How every customer creates their own brand reality https://t.co/5nFO2GQQ3e
Free access to all OnDemand eSymposia content. Available to all individuals from low-and middle-income countries working in science and medical-related field https://t.co/EW2y6ZeajB #esymposia#VKS
Free access to all OnDemand eSymposia content. Available to all individuals from low-and middle-income countries
working in science and medical-related field https://t.co/FiuJUffwtv
Tune in to #Autophagy virtual #eSymposia on Monday for plenary sessions & interactive opportunities to connect with speakers and editors from @CellPressNews and other top tier journals. Register to make personal appointments with the 1:1 connect feature.
https://t.co/YRgDN7pB6a
Connect with editors from leading journals like @CellPressNews at the upcoming #RNAEditing and #RNAModifications#eSymposia starting tomorrow!
Register now for interactive features like 1:1 Connect for private appointments with speakers and editors!
https://t.co/F4WEtNcqLT
@KeystoneSymp fellows and #BlackinMicro organizers @KizzyPhD & @blacksciblog featured this morning in the @nytimes on race, science & this weeks' @BlackInMicro events celebrating & uniting black microbiologists across the world.
https://t.co/8xw15TbB3M
https://t.co/yB4zr3xv93
Make sure to attend a key event this season: October @KeystoneSymp virtual meeting, Autophagy: Mechanisms and Disease, featuring new frontiers in #autophagy research advances from field leaders. Register today at https://t.co/wwmOHe2yNI #VKSAutophagy21#eSymposia
JCB is pleased to join the @KeystoneSymp virtual meeting in October, "Autophagy: Mechanisms and Disease," featuring new frontiers in #autophagy research advances from field leaders. Register today at https://t.co/W0JTww8RtJ #VKSAutophagy21#eSymposia
The rapid evolution of virtual scientific conferences https://t.co/fRg2izXv0J
Dr Thale Jarvis, @KeystoneSymp CSO provides her perspective on Virtual Conferences
#eSymposia#ScienceMustGoON
Submit an abstract by 9/22 for short talk consideration at upcoming virtual #eSymposia, Optimizing Nutrition for Maternal, Newborn & Child Health. Present your research alongside field leaders including @Shinjini_Bhtngr, @k_semrau, @YoelSadovsky & more.
https://t.co/vIlrUUdnor
Join us to explore growing applications of #RNAediting, described in @Labiotech_eu below, at virtual #eSymposia this October.
Abstract submissions & Scholarship applications for FREE registration are due TOMORROW 9/9.
https://t.co/DZYoETWghF
https://t.co/wsoD4d6Xf0
Science Must Go On. https://t.co/7Jm06kemEu @KeystoneSymp CEO/Prez Dr Johnson introduces #eSymposia virtual meeting series. Learn more by visiting https://t.co/f6Mrlx6no9 #ScienceMustGoOn
Join me in October for the @KeystoneSymp virtual meeting, RNA Editing and Modifications: From Biology to Therapy, featuring new frontiers in #RNAediting research. Register today at https://t.co/hemYilc1YR #VKSRNAEditing21#eSymposia
Echoing @PritiHegde in her closing remarks to #VKScancerimmuno20, thank you to the 550 participants from 35 countries for an amazing #eSymposia virtual meeting! Sessions will be available on-demand later this week and check out upcoming virtual events.
https://t.co/5qw3CTNdtY
JEM is pleased to take part in the @KeystoneSymp "Advances in Cancer Immunotherapy" on Aug 17-19 (https://t.co/Spqpik0DV0). To accompany the meeting, we present a special collection of recent articles & reviews on the subjects: https://t.co/dM4zcRm8kw #VKScancerimmuno20